Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: Mesenchymal Stem Cells for Chronic Kidney Diseases [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update notes a Phase 1/2 study evaluating mesenchymal stem cells for chronic kidney disease, not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The First Affiliated Hospital of Air Force Medicial University | Conditions: Kidney Disease, Chronic, Diabetic Kidney Disease (DKD) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING